Peripheral Arterial Disease
Cardiovascular·MeSH: Peripheral Arterial Disease
Prevalence
1581.5 / 100K
Incidence
164.2 / 100K/yr
4 drugs in development·4 companies·17 clinical trials
Drug Pipeline by Phase
Approved(1)
Phase 3(1)
| Drug | Company |
|---|---|
| ferumoxytol | AMAG PHARMACEUTICALS, INC. (AMAG) |
Phase 2(1)
| Drug | Company |
|---|---|
| PDA-002 | Celularity Inc. (CELU) |
Preclinical(1)
| Drug | Company |
|---|---|
| proflow | SCICLONE PHARMACEUTICALS INC (SCLN) |
Compare drugs
Frequently asked questions
How many drugs are in development for Peripheral Arterial Disease?
BioSniper tracks 4 drugs in development for Peripheral Arterial Disease across 4 companies.
How many clinical trials target Peripheral Arterial Disease?
There are 17 clinical trials targeting Peripheral Arterial Disease tracked by BioSniper.
What is the prevalence of Peripheral Arterial Disease?
The estimated prevalence of Peripheral Arterial Disease is approximately 1581.5 per 100,000 population.
Deep-dive into Peripheral Arterial Disease
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis